v3.25.4
Business (Tables)
6 Months Ended
Dec. 31, 2025
Schedule Of Entities In Control [Abstract]  
Summary of entities in control

The consolidated financial statements of Benitec Biopharma Inc. are presented in United States dollars and consist of Benitec Biopharma Inc. and its wholly owned subsidiaries as listed below. Aside from Benitec Biopharma Proprietary Limited, the international subsidiaries are dormant.

 

 

 

Principal place of

business/country of

incorporation

Benitec Biopharma Proprietary Limited (“BBL”)

 

Australia

Benitec Australia Proprietary Limited

 

Australia

Benitec Limited

 

United Kingdom

Benitec, Inc.

 

USA

Benitec LLC

 

USA

RNAi Therapeutics, Inc.

 

USA

Tacere Therapeutics, Inc.

 

USA

Benitec IP Holdings, Inc.

 

USA